Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report

<p><br></p><p dir="ltr">Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a c...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Mohamad Y. Khatib (11659459) (author)
مؤلفون آخرون: Solaiman M. Allafi (14777275) (author), Abdulqadir J. Nashwan (11659453) (author)
منشور في: 2020
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513566103568384
author Mohamad Y. Khatib (11659459)
author2 Solaiman M. Allafi (14777275)
Abdulqadir J. Nashwan (11659453)
author2_role author
author
author_facet Mohamad Y. Khatib (11659459)
Solaiman M. Allafi (14777275)
Abdulqadir J. Nashwan (11659453)
author_role author
dc.creator.none.fl_str_mv Mohamad Y. Khatib (11659459)
Solaiman M. Allafi (14777275)
Abdulqadir J. Nashwan (11659453)
dc.date.none.fl_str_mv 2020-12-08T09:00:00Z
dc.identifier.none.fl_str_mv 10.1002/ccr3.3642
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Serum_sickness_following_rituximab_therapy_in_a_patient_with_pemphigus_vulgaris_A_case_report/22257598
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Human antichimeric antibodies
Immunosuppressant
Pemphigus vulgaris
Rituximab
Serum sickness
dc.title.none.fl_str_mv Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p><br></p><p dir="ltr">Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patient with rituximab for pemphigus vulgaris.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3642" target="_blank">http://dx.doi.org/10.1002/ccr3.3642</a></p>
eu_rights_str_mv openAccess
id Manara2_975cc6602a2c732a24ea5811aaf79829
identifier_str_mv 10.1002/ccr3.3642
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/22257598
publishDate 2020
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case reportMohamad Y. Khatib (11659459)Solaiman M. Allafi (14777275)Abdulqadir J. Nashwan (11659453)Biomedical and clinical sciencesClinical sciencesImmunologyPharmacology and pharmaceutical sciencesHuman antichimeric antibodiesImmunosuppressantPemphigus vulgarisRituximabSerum sickness<p><br></p><p dir="ltr">Serum sickness, a reaction presenting with a classic triad (fever, rash, myalgia/arthralgia), is considered as a rare adverse event following monoclonal antibodies and specifically following treatment with rituximab. This report describes a case of serum sickness in a newly treated young male patient with rituximab for pemphigus vulgaris.</p><h2>Other Information</h2><p dir="ltr">Published in: Clinical Case Reports<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="http://dx.doi.org/10.1002/ccr3.3642" target="_blank">http://dx.doi.org/10.1002/ccr3.3642</a></p>2020-12-08T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1002/ccr3.3642https://figshare.com/articles/journal_contribution/Serum_sickness_following_rituximab_therapy_in_a_patient_with_pemphigus_vulgaris_A_case_report/22257598CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/222575982020-12-08T09:00:00Z
spellingShingle Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
Mohamad Y. Khatib (11659459)
Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Human antichimeric antibodies
Immunosuppressant
Pemphigus vulgaris
Rituximab
Serum sickness
status_str publishedVersion
title Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
title_full Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
title_fullStr Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
title_full_unstemmed Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
title_short Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
title_sort Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
topic Biomedical and clinical sciences
Clinical sciences
Immunology
Pharmacology and pharmaceutical sciences
Human antichimeric antibodies
Immunosuppressant
Pemphigus vulgaris
Rituximab
Serum sickness